FITC-Dextran (MW 10000)
FITC-Dextran (MW 10000) is a fluorescent probe for fluorescein isothiocyanate (FITC) dextran (Ex=495 nm; Em=525 nm) . FITC-Dextran (MW 10000) can be used as a marker to reveal heat shock-induced cell damage and to study the early and late stages of apoptosis. FITC-Dextran (MW 10000) can also be used for cell permeability studies, such as blood-brain barrier permeability and determination of the extent of blood-brain barrier disruption[1][2][3].
Product Specifications
CAS Number
[60842-46-8]
UNSPSC
12171500
Hazard Statement
H315, H319, H335
Target
Fluorescent Dye
Type
Dye Reagents
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/fitc-dextran.html
Solubility
H2O : 50 mg/mL (ultrasonic)
Smiles
[FITC-Dextran(MW10000)]
Molecular Weight
10000.00 (Average)
Precautions
H315, H319, H335
References & Citations
[1]Moumaris M, et al. Fluorescein isothiocyanate-dextran can track apoptosis and necrosis induced by heat shock of peripheral blood mononuclear cells and HeLa cells[J]. Open Biological Sciences Journal, 2015, 1 (1) .|[2]Natarajan R, et al. Fluorescein Isothiocyanate (FITC) -Dextran Extravasation as a Measure of Blood-Brain Barrier Permeability. Curr Protoc Neurosci. 2017 Apr 10;79:9.58.1-9.58.15.|[3]Eriksson I, et al. Analysis of Lysosomal pH by Flow Cytometry Using FITC-Dextran Loaded Cells. Methods Mol Biol. 2017;1594:179-189.|[4]Okabayashi K, et al. Cdc42 activates paracellular transport in polarised submandibular gland cells. Arch Oral Biol. 2021 Dec;132:105276.|[5]Yu W, et al. ACE2 contributes to the maintenance of mouse epithelial barrier function. Biochem Biophys Res Commun. 2020 Dec 17;533 (4) :1276-1282.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Dye Reagents
Clinical Information
No Development Reported
Citation 01
Acta Pharmacol Sin. 2025 May;46 (5) :1345-1360.|Adv Sci (Weinh) . 2021 Oct;8 (20) :e2101912.|Biochem Biophys Rep. 2025 Nov 11:44:102351.|Cancer Lett. 2024 Jun 1:591:216897.|Cell Tissue Res. 2022 Sep;389 (3) :517-530.|Exp Brain Res. 2021 Jan;239 (1) :341-350.|Exp Ther Med. 2025 Nov 14;31 (1) :22. |Front Pharmacol. 2024 Aug 29:15:1428572.|Heliyon. 2023 Jul 16;9 (7) :e18325.|Immun Inflamm Dis. 2022 Oct;10 (10) :e697.|Immun Inflamm Dis. 2024 Dec;12 (12) :e70107.|Immunobiology. 2023 Mar;228 (2) :152315.|Int J Biol Macromol. 2025 May 9:144084.|Int J Hyperthermia. 2025 Dec;42 (1) :2559022.|J Funct Foods. 2024 Nov.|J Nanobiotechnology. 2025 Apr 15;23 (1) :291.|J Steroid Biochem Mol Biol. 2023 Jul:231:106314.|J Tradit Complement Med. 2024 Apr 29.|J Transl Med. 2024 Jun 5;22 (1) :535.|J Vis Exp. 2024 Dec 20: (214) .|Kaohsiung J Med Sci. 2024 Aug;40 (8) :710-721.|Nat Commun. 2024 Jan 19;15 (1) :613.|Nat Metab. 2022 Sep;4 (9) :1138-1149.|PLoS Pathog. 2025 Jan 2;21 (1) :e1012800.|Prev Nutr Food Sci. 2024 Dec 31;29 (4) :474-484.|Research Square Print. 2023 Feb 23.|SSRN. 2023 Jun 12.|SSRN. 2025 Mar 11.|Theranostics. 2023 Mar 27;13 (6) :2040-2056.|Adv Sci (Weinh) . 2025 Aug;12 (30) :e00461.|Adv Sci (Weinh) . 2025 Jan 9:e2412526.|Adv Sci (Weinh) . 2025 Jul 18:e00741.|Biochem Biophys Res Commun. 2020 Dec 17;533 (4) :1276-1282.|Biochem Biophys Res Commun. 2024 Sep 3:723:150176.|Bioengineered. 2022 Feb;13 (2) :3680-3693.|Bioengineered. 2022 Mar;13 (3) :7209-7220.|Biomaterials. 2022 Aug:287:121608.|Biomed Pharmacother. 2024 Jun:175:116633.|bioRxiv. 2025 May 11.|BMC Infect Dis. 2025 Apr 20;25 (1) :565.|Brain Behav Immun. 2023 May:110:140-151.|Cell Commun Signal. 2025 Jun 4;23 (1) :263.|Cell Rep. 2023 Apr 4;42 (4) :112346.|Cell Rep. 2023 Jun 20;42 (7) :112660.|Curr Issues Mol Biol. 2022 Nov 29;44 (12) :5995-6005.|Device. 2024 June 12|EBioMedicine. 2022 Aug:82:104181.|Ecotoxicol Environ Saf. 2024 Jul 23:282:116762.|Eur J Histochem. 2025 Jan 21;69 (1) .|Exp Brain Res. 2021 Jan;239 (1) :341-350.|FEBS J. 2025 Mar;292 (5) :1052-1069.|FEBS J. 2025 Nov 27.|Food Funct. 2021 Nov 29;12 (23) :11956-11965.|Front Pharmacol. 2021 Nov 2:12:748568.|Gut Microbes. 2024 Jan-Dec;16 (1) :2377576.|iMetaOmics. 2025 Aug 06.|Int Immunopharmacol. 2024 May 23:135:112263.|Int Immunopharmacol. 2025 Jan 17:148:113972.|Int J Biol Macromol. 2025 May 9:144084.|Int J Mol Sci. 2025 Oct 19;26 (20) :10161.|Int J Radiat Oncol Biol Phys. 2025 Sep 16:S0360-3016 (25) 06272-8.|J Ethnopharmacol. 2024 Jan 30;319 (Pt 1) :117098.|J Ethnopharmacol. 2024 Mar 25:322:117567.|J Ethnopharmacol. 2024 Nov 9;338 (Pt 2) :119068.|J Ethnopharmacol. 2024 Oct 16;337 (Pt 3) :118937.|J Ethnopharmacol. 2025 Apr 6:119744.|J Ethnopharmacol. 2025 Aug 18;353 (Pt B) :120435.|J Neurotrauma. 2025 Aug 29.|Mol Med Rep. 2024 Jun;29 (6) :90.|Mol Neurobiol. 2025 Apr;62 (4) :4203-4220.|Mucosal Immunol. 2024 Sep 6:S1933-0219 (24) 00093-X.|Neurotox Res. 2022 Aug;40 (4) :1020-1028.|Pharmacol Res. 2024 May 21:205:107229.|Phytomedicine. 2023 Jul 25:116:154825.|Probiotics Antimicrob Proteins. 2025 Nov 26.|Redox Rep. 2024 Dec;29 (1) :2433393.|Res Sq. 2024 Aug 13.|Research Square Preprint. 2023 Oct 10.|Research Square Preprint. 2023 Oct 23.|Research Square Preprint. 2024 Apr 9.|Sci Adv. 2023 Oct 20;9 (42) :eadi0699.|Sci China Life Sci. 2025 Jul;68 (7) :2010-2027.|Signal Transduct Target Ther. 2025 Nov 14;10 (1) :368.|SSRN. 2025 May 21.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
